6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: May 20, 2022
Period of Report: May 20, 2022
Accession Number: 0001213900-22-028604

View Document ↗ View on SEC.gov ↗